Literature DB >> 10749750

Effect of erythromycin on ATP-induced intracellular calcium response in A549 cells.

D M Zhao1, H H Xue, K Chida, T Suda, Y Oki, M Kanai, C Uchida, A Ichiyama, H Nakamura.   

Abstract

ATP induced a biphasic increase in the intracellular Ca(2+)concentration ([Ca(2+)](i)), an initial spike, and a subsequent plateau in A549 cells. Erythromycin (EM) suppressed the ATP-induced [Ca(2+)](i) spike but only in the presence of extracellular calcium (Ca(2+)(o)). It was ineffective against ATP- and UTP-induced inositol 1,4,5-trisphosphate [Ins(1,4,5)P(3)] formation and UTP-induced [Ca(2+)](i) spike, implying that EM perturbs Ca(2+) influx from the extracellular space rather than Ca(2+)release from intracellular Ca(2+) stores via the G protein-phospholipase C-Ins(1,4,5)P(3) pathway. A verapamil-sensitive, KCl-induced increase in [Ca(2+)](i) and the Ca(2+) influx activated by Ca(2+) store depletion were insensitive to EM. 3'-O-(4-benzoylbenzoyl)-ATP evoked an Ca(2+)(o)-dependent [Ca(2+)](i) response even in the presence of verapamil or the absence of extracellular Na(+), and this response was almost completely abolished by EM pretreatment. RT-PCR analyses revealed that P2X(4) as well as P2Y(2), P2Y(4), and P2Y(6) are coexpressed in this cell line. These results suggest that in A549 cells 1) the coexpressed P2X(4) and P2Y(2)/P2Y(4) subtypes contribute to the ATP-induced [Ca(2+)](i) spike and 2) EM selectively inhibits Ca(2+) influx through the P2X channel. This action of EM may underlie its clinical efficacy in the treatment of airway inflammation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10749750     DOI: 10.1152/ajplung.2000.278.4.L726

Source DB:  PubMed          Journal:  Am J Physiol Lung Cell Mol Physiol        ISSN: 1040-0605            Impact factor:   5.464


  13 in total

1.  The Concise Guide to PHARMACOLOGY 2013/14: G protein-coupled receptors.

Authors:  Stephen P H Alexander; Helen E Benson; Elena Faccenda; Adam J Pawson; Joanna L Sharman; Michael Spedding; John A Peters; Anthony J Harmar
Journal:  Br J Pharmacol       Date:  2013-12       Impact factor: 8.739

2.  Altered purinergic receptor-Ca²⁺ signaling associated with hypoxia-induced epithelial-mesenchymal transition in breast cancer cells.

Authors:  Iman Azimi; Hannah Beilby; Felicity M Davis; Daneth L Marcial; Paraic A Kenny; Erik W Thompson; Sarah J Roberts-Thomson; Gregory R Monteith
Journal:  Mol Oncol       Date:  2015-09-25       Impact factor: 6.603

Review 3.  Mechanisms of action and clinical application of macrolides as immunomodulatory medications.

Authors:  Soichiro Kanoh; Bruce K Rubin
Journal:  Clin Microbiol Rev       Date:  2010-07       Impact factor: 26.132

Review 4.  Purinergic signalling and cancer.

Authors:  Geoffrey Burnstock; Francesco Di Virgilio
Journal:  Purinergic Signal       Date:  2013-12       Impact factor: 3.765

5.  Ca2+-dependent ATP release from A549 cells involves synergistic autocrine stimulation by coreleased uridine nucleotides.

Authors:  Sabina Tatur; Nicolas Groulx; Sergei N Orlov; Ryszard Grygorczyk
Journal:  J Physiol       Date:  2007-08-16       Impact factor: 5.182

6.  The antibiotic azithromycin is a motilin receptor agonist in human stomach: comparison with erythromycin.

Authors:  John Broad; Gareth J Sanger
Journal:  Br J Pharmacol       Date:  2013-04       Impact factor: 8.739

7.  Regional- and agonist-dependent facilitation of human neurogastrointestinal functions by motilin receptor agonists.

Authors:  J Broad; S Mukherjee; M Samadi; J E Martin; G E Dukes; G J Sanger
Journal:  Br J Pharmacol       Date:  2012-10       Impact factor: 8.739

Review 8.  Autocrine and paracrine purinergic signaling in the most lethal types of cancer.

Authors:  M Reyna-Jeldes; M Díaz-Muñoz; J A Madariaga; C Coddou; F G Vázquez-Cuevas
Journal:  Purinergic Signal       Date:  2021-05-12       Impact factor: 3.765

9.  Suppression of nitric oxide production from nasal fibroblasts by metabolized clarithromycin in vitro.

Authors:  Ayako Furuya; Kazuhito Asano; Naruo Shoji; Kojiro Hirano; Taisuke Hamasaki; Harumi Suzaki
Journal:  J Inflamm (Lond)       Date:  2010-11-23       Impact factor: 4.981

10.  Motilin: towards a new understanding of the gastrointestinal neuropharmacology and therapeutic use of motilin receptor agonists.

Authors:  G J Sanger; Y Wang; A Hobson; J Broad
Journal:  Br J Pharmacol       Date:  2013-12       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.